- published: 17 Jan 2017
- views: 3849
-
remove the playlistAcute Promyelocytic Leukemia
- remove the playlistAcute Promyelocytic Leukemia
Acute promyelocytic leukemia
Acute promyelocytic leukemia (APML, APL) is the M3 subtype of acute myelogenous leukemia (AML), a cancer of the white blood cells. In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy. Acute promyelocytic leukemia was first characterized in 1957 by French and Norwegian physicians as a hyperacute fatal illness. Currently it is one of the most treatable forms of leukemia with a 12-year progression-free survival rate that is estimated to be approximately 70%.
Signs and symptoms
The symptoms tend to be similar to AML in general with the following being possible symptoms:
This page contains text from Wikipedia, the Free Encyclopedia - https://wn.com/Acute_promyelocytic_leukemia
Podcasts:
-
Timely Diagnosis of Acute Promyelocytic Leukemia
Ehab Atallah, MD, and Elihu Estey, MD, discuss differential diagnosis, testing, and initiation of treatment in acute promyelocytic leukemia (APL).
published: 17 Jan 2017 -
Acute Promyelocytic Leukemia | Jaclyn's Story
Jaclyn was diagnosed with a rare subtype of acute myeloid leukemia (AML) -- acute promyelocytic leukemia -- requiring immediate treatment. See how Dr. Gail Roboz and the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian went above and beyond to help Jaclyn achieve remission and kickstart a healthy lifestyle. Learn more about our Leukemia Program: https://weillcornell.org/leukemia
published: 18 Dec 2019 -
Treating Acute Promyelocytic Leukemia (APL)
Anand P. Jillella, MD of the Winship Cancer Institute of Atlanta, GA, discusses best practices, treatment, standard of care for APL, role of clinical trials, complications that may arise during treatment, treating a relapsed patient, and the importance of a good relationship with your patients. Kaitlin L. Sitchenko, CCRC discusses the role of clinical trials in treatment. APL survivors, Julie and June each share their story about their APL diagnosis and treatment. To view additional videos, visit http://www.LLS.org/educationvideos. or your feedback at http://www.cancereducation.com/cancer.... Support for this video provided by Teva Oncology.
published: 30 Dec 2015 -
Acute Promyelocytic Leukemia (APL): microgranular vs classic (cottage loaf cells). Hematology
This clip is an excerpt from a Hemepath Board Review video by special guest, Dr. Jeanette Ramos (full video here: https://kikoxp.com/posts/3726). If you missed Dr. Ramos's first guest lecture discussing the histology and immunostaining patterns of non-neoplastic lymph nodes, check it out here: https://kikoxp.com/posts/4068. If you like Dr. Ramos's cases and teaching style, be sure to follow UAMS Hematopathology on social media, as she often contributes to their accounts: - https://twitter.com/hemepathuams - https://www.facebook.com/hemepathUAMS/ This video is geared towards medical students, pathology/internal medicine/family practice residents, hematology or hematopathology fellows, or practicing pathologists or hematologists. Of course, this video is for educational purposes only and ...
published: 29 Mar 2021 -
Acute Promyelocytic Leukema (aPML) - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology
Acute Promyelocytic Leukema (aPML) - Acute Myeloid Leukemia (AML) Subtype: M3 - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology. Acute Promyelocytic Leukema (aPML) is a chromosomal translocation: t(15;17) translocation...AML-M3 is associated with disseminated intravascular coagulation (DIC)...Treated with ATRA (tretinoin) which is vitamin A (can cause differentiation syndrome). aPML can also be treated with Arsenic trioxide. 😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/ Disclaimer: I use affiliate links.... ►👨🏫💊Antibiotics Lectures: https://www.medicosisperfectionalis.com/products/courses/antibiotics/ ... Course If you like my videos, please consider leaving a tip at https://www.paypal.me/perfectionalis/ ► Visit my website: https:...
published: 24 Jul 2018 -
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy, discusses the use of a chemo-free approach combining arsenic trioxide (ATO) with all-trans retinoic acid (ATRA), which is superior to a conventional approach in the treatment of acute promyelocytic leukemia (APL, APML). He describes how this will now be examined in a randomized study in high-risk APML patients comparing arsenic in combination with all-trans-retinoic acid to chemotherapy. Prof. Lo-Coco explains that high-risk APML patients are defined as those with an initial white blood cell count greater than 10 000. The trial aims to demonstrate a benefit in event-free survival (EFS) using the new compound. Prof. Lo Coco points out that APML is now a highly curable disease, and explains that the hope is to come to a new...
published: 07 Mar 2017 -
Kate Stallard - Acute Promyelocytic Leukaemia patient story
published: 01 Oct 2018 -
Acute Promyelocytic Leukemia(AML M3) | Dr. G Krishna Reddy| Oncologists| Manipal Hospital Vijayawada
Acute Promyelocytic Leukaemia (AML M3) is a type of blood cancer that causes immature and abnormal neutrophils, a type of white blood cell, to accumulate in a patient’s bone marrow. In this video, Dr. G Krishna Reddy, Consultant – Medical Oncologist and Bone Marrow Transplant Physician, Manipal Hospital Vijayawada, shares details about this condition and discusses treatment options. At Manipal Hospital Vijayawada, our Centre of Excellence in Oncology (Cancer Care) adopts a holistic approach to provide the complete treatment of an entire spectrum of cancers at all stages. With expertise in all clinical specialties in oncology, such as medical (immunotherapy, targeted therapy, hormone therapy and chemotherapy), surgical, haematology, bone marrow transplant and radiation therapy, our profic...
published: 11 Jan 2023 -
Acute promyelocytic leukemia (APL) illness script video
More content on RLRCPSolvers.com Myeloblast w/ Auer rod https://imagebank.hematology.org/atlas/60924 Microgranular variant (no Auer rods or granules but the bi-lobed nuclei are the tip-off) https://imagebank.hematology.org/collection/111
published: 26 Jan 2024 -
ACUTE PROMYELOCYTIC LEUKEMIA – SYMPTOMS, TREATMENT & SUPPORT
What Is Acute Promyelocytic Leukemia? https://withoutaribbon.org/acute-promyelocytic-leukemia-symptoms-treatment-support/ Acute Promyelocytic #Leukemia is a bone marrow malignancy in which the myeloid line of cells( red blood cells, white blood cells and platelets forming cells) has a shortage of mature white blood cells and an excess of immature progenitor (ancestor) white blood cells, called promyelocytes. Disease Epidemiology Acute Promyelocytic Leukemia (APL) constitutes 5-15 per cent of all adult leukemia in the United States. #APL in Italy has an annual incidence rate (frequency of occurrence of disease) of around 0.6 per 1 million populations. Both males and females are equally affected. The age of onset of the disease is about 40 years. Disease Prognosis Unlike other leukemias, ...
published: 07 Feb 2023
3:52
Timely Diagnosis of Acute Promyelocytic Leukemia
- Order: Reorder
- Duration: 3:52
- Uploaded Date: 17 Jan 2017
- views: 3849
Ehab Atallah, MD, and Elihu Estey, MD, discuss differential diagnosis, testing, and initiation of treatment in acute promyelocytic leukemia (APL).
Ehab Atallah, MD, and Elihu Estey, MD, discuss differential diagnosis, testing, and initiation of treatment in acute promyelocytic leukemia (APL).
https://wn.com/Timely_Diagnosis_Of_Acute_Promyelocytic_Leukemia
Ehab Atallah, MD, and Elihu Estey, MD, discuss differential diagnosis, testing, and initiation of treatment in acute promyelocytic leukemia (APL).
5:05
Acute Promyelocytic Leukemia | Jaclyn's Story
- Order: Reorder
- Duration: 5:05
- Uploaded Date: 18 Dec 2019
- views: 7982
Jaclyn was diagnosed with a rare subtype of acute myeloid leukemia (AML) -- acute promyelocytic leukemia -- requiring immediate treatment. See how Dr. Gail Robo...
Jaclyn was diagnosed with a rare subtype of acute myeloid leukemia (AML) -- acute promyelocytic leukemia -- requiring immediate treatment. See how Dr. Gail Roboz and the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian went above and beyond to help Jaclyn achieve remission and kickstart a healthy lifestyle.
Learn more about our Leukemia Program:
https://weillcornell.org/leukemia
https://wn.com/Acute_Promyelocytic_Leukemia_|_Jaclyn's_Story
Jaclyn was diagnosed with a rare subtype of acute myeloid leukemia (AML) -- acute promyelocytic leukemia -- requiring immediate treatment. See how Dr. Gail Roboz and the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian went above and beyond to help Jaclyn achieve remission and kickstart a healthy lifestyle.
Learn more about our Leukemia Program:
https://weillcornell.org/leukemia
- published: 18 Dec 2019
- views: 7982
17:42
Treating Acute Promyelocytic Leukemia (APL)
- Order: Reorder
- Duration: 17:42
- Uploaded Date: 30 Dec 2015
- views: 21205
Anand P. Jillella, MD of the Winship Cancer Institute of Atlanta, GA, discusses best practices, treatment, standard of care for APL, role of clinical trials, co...
Anand P. Jillella, MD of the Winship Cancer Institute of Atlanta, GA, discusses best practices, treatment, standard of care for APL, role of clinical trials, complications that may arise during treatment, treating a relapsed patient, and the importance of a good relationship with your patients. Kaitlin L. Sitchenko, CCRC discusses the role of clinical trials in treatment. APL survivors, Julie and June each share their story about their APL diagnosis and treatment.
To view additional videos, visit http://www.LLS.org/educationvideos.
or your feedback at http://www.cancereducation.com/cancer....
Support for this video provided by Teva Oncology.
https://wn.com/Treating_Acute_Promyelocytic_Leukemia_(Apl)
Anand P. Jillella, MD of the Winship Cancer Institute of Atlanta, GA, discusses best practices, treatment, standard of care for APL, role of clinical trials, complications that may arise during treatment, treating a relapsed patient, and the importance of a good relationship with your patients. Kaitlin L. Sitchenko, CCRC discusses the role of clinical trials in treatment. APL survivors, Julie and June each share their story about their APL diagnosis and treatment.
To view additional videos, visit http://www.LLS.org/educationvideos.
or your feedback at http://www.cancereducation.com/cancer....
Support for this video provided by Teva Oncology.
- published: 30 Dec 2015
- views: 21205
5:10
Acute Promyelocytic Leukemia (APL): microgranular vs classic (cottage loaf cells). Hematology
- Order: Reorder
- Duration: 5:10
- Uploaded Date: 29 Mar 2021
- views: 6524
This clip is an excerpt from a Hemepath Board Review video by special guest, Dr. Jeanette Ramos (full video here: https://kikoxp.com/posts/3726). If you missed ...
This clip is an excerpt from a Hemepath Board Review video by special guest, Dr. Jeanette Ramos (full video here: https://kikoxp.com/posts/3726). If you missed Dr. Ramos's first guest lecture discussing the histology and immunostaining patterns of non-neoplastic lymph nodes, check it out here: https://kikoxp.com/posts/4068.
If you like Dr. Ramos's cases and teaching style, be sure to follow UAMS Hematopathology on social media, as she often contributes to their accounts:
- https://twitter.com/hemepathuams
- https://www.facebook.com/hemepathUAMS/
This video is geared towards medical students, pathology/internal medicine/family practice residents, hematology or hematopathology fellows, or practicing pathologists or hematologists. Of course, this video is for educational purposes only and is not formal medical advice or consultation. Neither Dr. Ramos nor Dr. Gardner have any special inside knowledge of the content of the path/heme/hemepath/USMLE board examinations. This video is subjectively labeled as a "board review" purely because we believe these topics are potentially testable entities, not because we have any knowledge about the frequency that they will show up on actual board exams.
Please subscribe to my channel to be notified of new pathology teaching videos.
Follow me on:
Snapchat: JMGardnerMD
Twitter: @JMGardnerMD
Instagram: @JMGardnerMD
Kiko: https://kikoxp.com/profile/jerad_gardner1/content?filter=popular
Facebook: https://www.facebook.com/JMGardnerMD/
https://wn.com/Acute_Promyelocytic_Leukemia_(Apl)_Microgranular_Vs_Classic_(Cottage_Loaf_Cells)._Hematology
This clip is an excerpt from a Hemepath Board Review video by special guest, Dr. Jeanette Ramos (full video here: https://kikoxp.com/posts/3726). If you missed Dr. Ramos's first guest lecture discussing the histology and immunostaining patterns of non-neoplastic lymph nodes, check it out here: https://kikoxp.com/posts/4068.
If you like Dr. Ramos's cases and teaching style, be sure to follow UAMS Hematopathology on social media, as she often contributes to their accounts:
- https://twitter.com/hemepathuams
- https://www.facebook.com/hemepathUAMS/
This video is geared towards medical students, pathology/internal medicine/family practice residents, hematology or hematopathology fellows, or practicing pathologists or hematologists. Of course, this video is for educational purposes only and is not formal medical advice or consultation. Neither Dr. Ramos nor Dr. Gardner have any special inside knowledge of the content of the path/heme/hemepath/USMLE board examinations. This video is subjectively labeled as a "board review" purely because we believe these topics are potentially testable entities, not because we have any knowledge about the frequency that they will show up on actual board exams.
Please subscribe to my channel to be notified of new pathology teaching videos.
Follow me on:
Snapchat: JMGardnerMD
Twitter: @JMGardnerMD
Instagram: @JMGardnerMD
Kiko: https://kikoxp.com/profile/jerad_gardner1/content?filter=popular
Facebook: https://www.facebook.com/JMGardnerMD/
- published: 29 Mar 2021
- views: 6524
7:29
Acute Promyelocytic Leukema (aPML) - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology
- Order: Reorder
- Duration: 7:29
- Uploaded Date: 24 Jul 2018
- views: 87880
Acute Promyelocytic Leukema (aPML) - Acute Myeloid Leukemia (AML) Subtype: M3 - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology.
Acute Promyelocytic...
Acute Promyelocytic Leukema (aPML) - Acute Myeloid Leukemia (AML) Subtype: M3 - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology.
Acute Promyelocytic Leukema (aPML) is a chromosomal translocation: t(15;17) translocation...AML-M3 is associated with disseminated intravascular coagulation (DIC)...Treated with ATRA (tretinoin) which is vitamin A (can cause differentiation syndrome). aPML can also be treated with Arsenic trioxide.
😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/
Disclaimer: I use affiliate links....
►👨🏫💊Antibiotics Lectures: https://www.medicosisperfectionalis.com/products/courses/antibiotics/ ... Course
If you like my videos, please consider leaving a tip at https://www.paypal.me/perfectionalis/
► Visit my website: https://www.medicosisperfectionalis.com/
My Favorite Productivity App: https://airtable.com/invite/r/2zH40fus/
📱Save on your mobile phone bill: http://fbuy.me/q6bMj
🏦 Qbank (TrueLearn): https://truelearn.referralrock.com/l/MEDICOSIS/
https://wn.com/Acute_Promyelocytic_Leukema_(Apml)_Aml_M3_Subtype_T(15_17)_Vitamin_A_(Atra)_Hematology
Acute Promyelocytic Leukema (aPML) - Acute Myeloid Leukemia (AML) Subtype: M3 - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology.
Acute Promyelocytic Leukema (aPML) is a chromosomal translocation: t(15;17) translocation...AML-M3 is associated with disseminated intravascular coagulation (DIC)...Treated with ATRA (tretinoin) which is vitamin A (can cause differentiation syndrome). aPML can also be treated with Arsenic trioxide.
😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/
Disclaimer: I use affiliate links....
►👨🏫💊Antibiotics Lectures: https://www.medicosisperfectionalis.com/products/courses/antibiotics/ ... Course
If you like my videos, please consider leaving a tip at https://www.paypal.me/perfectionalis/
► Visit my website: https://www.medicosisperfectionalis.com/
My Favorite Productivity App: https://airtable.com/invite/r/2zH40fus/
📱Save on your mobile phone bill: http://fbuy.me/q6bMj
🏦 Qbank (TrueLearn): https://truelearn.referralrock.com/l/MEDICOSIS/
- published: 24 Jul 2018
- views: 87880
2:50
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
- Order: Reorder
- Duration: 2:50
- Uploaded Date: 07 Mar 2017
- views: 2333
Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy, discusses the use of a chemo-free approach combining arsenic trioxide (ATO) with all-trans ...
Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy, discusses the use of a chemo-free approach combining arsenic trioxide (ATO) with all-trans retinoic acid (ATRA), which is superior to a conventional approach in the treatment of acute promyelocytic leukemia (APL, APML). He describes how this will now be examined in a randomized study in high-risk APML patients comparing arsenic in combination with all-trans-retinoic acid to chemotherapy. Prof. Lo-Coco explains that high-risk APML patients are defined as those with an initial white blood cell count greater than 10 000. The trial aims to demonstrate a benefit in event-free survival (EFS) using the new compound. Prof. Lo Coco points out that APML is now a highly curable disease, and explains that the hope is to come to a new standard particularly avoiding toxicity. He is hopeful that the chemo-free approach can be expanded to high-risk patients, but highlights the challenges of this trial due to the fact that high-risk APML is a rare disease, exhibited by only a quarter of APML patients. Prof. Lo-Coco emphasizes the value of collaboration with other European partners in this trial.
https://wn.com/Chemo_Free_Approach_In_Acute_Promyelocytic_Leukemia_(Apl)_Treatment
Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy, discusses the use of a chemo-free approach combining arsenic trioxide (ATO) with all-trans retinoic acid (ATRA), which is superior to a conventional approach in the treatment of acute promyelocytic leukemia (APL, APML). He describes how this will now be examined in a randomized study in high-risk APML patients comparing arsenic in combination with all-trans-retinoic acid to chemotherapy. Prof. Lo-Coco explains that high-risk APML patients are defined as those with an initial white blood cell count greater than 10 000. The trial aims to demonstrate a benefit in event-free survival (EFS) using the new compound. Prof. Lo Coco points out that APML is now a highly curable disease, and explains that the hope is to come to a new standard particularly avoiding toxicity. He is hopeful that the chemo-free approach can be expanded to high-risk patients, but highlights the challenges of this trial due to the fact that high-risk APML is a rare disease, exhibited by only a quarter of APML patients. Prof. Lo-Coco emphasizes the value of collaboration with other European partners in this trial.
- published: 07 Mar 2017
- views: 2333
4:06
Kate Stallard - Acute Promyelocytic Leukaemia patient story
- Order: Reorder
- Duration: 4:06
- Uploaded Date: 01 Oct 2018
- views: 11838
- published: 01 Oct 2018
- views: 11838
27:39
Acute Promyelocytic Leukemia(AML M3) | Dr. G Krishna Reddy| Oncologists| Manipal Hospital Vijayawada
- Order: Reorder
- Duration: 27:39
- Uploaded Date: 11 Jan 2023
- views: 1006
Acute Promyelocytic Leukaemia (AML M3) is a type of blood cancer that causes immature and abnormal neutrophils, a type of white blood cell, to accumulate in a p...
Acute Promyelocytic Leukaemia (AML M3) is a type of blood cancer that causes immature and abnormal neutrophils, a type of white blood cell, to accumulate in a patient’s bone marrow. In this video, Dr. G Krishna Reddy, Consultant – Medical Oncologist and Bone Marrow Transplant Physician, Manipal Hospital Vijayawada, shares details about this condition and discusses treatment options.
At Manipal Hospital Vijayawada, our Centre of Excellence in Oncology (Cancer Care) adopts a holistic approach to provide the complete treatment of an entire spectrum of cancers at all stages. With expertise in all clinical specialties in oncology, such as medical (immunotherapy, targeted therapy, hormone therapy and chemotherapy), surgical, haematology, bone marrow transplant and radiation therapy, our proficient team of cancer specialists promises quality treatment and care.
They have years of experience in diagnosing some of the most challenging cases, staging the illness, treating with radiotherapy or medications and operating with state-of-the-art equipment and technology. To stay true to our ethos of patient centricity and clinical excellence, we prioritize quaternary care to ensure timely diagnosis and treatment of all cancers.
At Manipal Hospital Vijayawada, we have a dedicated tumour board for cancer patients. We believe that each patient is unique and thus, helps us learn about the various aspects of cancer care and treatment. With this dedicated tumour board, we encourage exhaustive discussions and studies on each case to come up with the best possible treatment. Moreover, we follow internationally approved and evidence-based chemotherapy guidelines for the treatment of haematological and solid cancers.
Know More
View Full Doctor Profile: https://www.manipalhospitals.com/vijayawada/doctors/dr-g-krishna-reddy-consultant-medical-oncologist-bone-marrow-transplant-physician/
Visit Our Hospital Website: https://www.manipalhospitals.com/
Visit Our Cancer Care Doctors: https://www.manipalhospitals.com/vijayawada/doctors-list/cancer-care/
Visit for Cancer Care Department: https://www.manipalhospitals.com/vijayawada/specialities/cancer-care/
Contact us @ https://www.manipalhospitals.com/contact-us/
Get Connected Here:
==================
Facebook: https://www.facebook.com/ManipalHospitalsIndia
Twitter: https://twitter.com/ManipalHealth
Pinterest: https://in.pinterest.com/manipalhospital
LinkedIn: https://www.linkedin.com/company/manipal-hospital
Instagram: https://www.instagram.com/manipalhospitals/
Foursquare: https://foursquare.com/manipalhealth
Alexa: https://www.alexa.com/siteinfo/manipalhospitals.com
Blog: https://www.manipalhospitals.com/vijayawada/blog/
#ManipalHospitalVijayawada #YourManipal #LifesOn #Healthcare #APML #Oncology #Leukaemia #Bonemarrowtransplant #Bloodcancer
For appointments call:-1800 102 5555
Visit:https://www.manipalhospitals.com/vijayawada/doctors/dr-g-krishna-reddy-consultant-medical-oncologist-bone-marrow-transplant-physician/
https://wn.com/Acute_Promyelocytic_Leukemia(Aml_M3)_|_Dr._G_Krishna_Reddy|_Oncologists|_Manipal_Hospital_Vijayawada
Acute Promyelocytic Leukaemia (AML M3) is a type of blood cancer that causes immature and abnormal neutrophils, a type of white blood cell, to accumulate in a patient’s bone marrow. In this video, Dr. G Krishna Reddy, Consultant – Medical Oncologist and Bone Marrow Transplant Physician, Manipal Hospital Vijayawada, shares details about this condition and discusses treatment options.
At Manipal Hospital Vijayawada, our Centre of Excellence in Oncology (Cancer Care) adopts a holistic approach to provide the complete treatment of an entire spectrum of cancers at all stages. With expertise in all clinical specialties in oncology, such as medical (immunotherapy, targeted therapy, hormone therapy and chemotherapy), surgical, haematology, bone marrow transplant and radiation therapy, our proficient team of cancer specialists promises quality treatment and care.
They have years of experience in diagnosing some of the most challenging cases, staging the illness, treating with radiotherapy or medications and operating with state-of-the-art equipment and technology. To stay true to our ethos of patient centricity and clinical excellence, we prioritize quaternary care to ensure timely diagnosis and treatment of all cancers.
At Manipal Hospital Vijayawada, we have a dedicated tumour board for cancer patients. We believe that each patient is unique and thus, helps us learn about the various aspects of cancer care and treatment. With this dedicated tumour board, we encourage exhaustive discussions and studies on each case to come up with the best possible treatment. Moreover, we follow internationally approved and evidence-based chemotherapy guidelines for the treatment of haematological and solid cancers.
Know More
View Full Doctor Profile: https://www.manipalhospitals.com/vijayawada/doctors/dr-g-krishna-reddy-consultant-medical-oncologist-bone-marrow-transplant-physician/
Visit Our Hospital Website: https://www.manipalhospitals.com/
Visit Our Cancer Care Doctors: https://www.manipalhospitals.com/vijayawada/doctors-list/cancer-care/
Visit for Cancer Care Department: https://www.manipalhospitals.com/vijayawada/specialities/cancer-care/
Contact us @ https://www.manipalhospitals.com/contact-us/
Get Connected Here:
==================
Facebook: https://www.facebook.com/ManipalHospitalsIndia
Twitter: https://twitter.com/ManipalHealth
Pinterest: https://in.pinterest.com/manipalhospital
LinkedIn: https://www.linkedin.com/company/manipal-hospital
Instagram: https://www.instagram.com/manipalhospitals/
Foursquare: https://foursquare.com/manipalhealth
Alexa: https://www.alexa.com/siteinfo/manipalhospitals.com
Blog: https://www.manipalhospitals.com/vijayawada/blog/
#ManipalHospitalVijayawada #YourManipal #LifesOn #Healthcare #APML #Oncology #Leukaemia #Bonemarrowtransplant #Bloodcancer
For appointments call:-1800 102 5555
Visit:https://www.manipalhospitals.com/vijayawada/doctors/dr-g-krishna-reddy-consultant-medical-oncologist-bone-marrow-transplant-physician/
- published: 11 Jan 2023
- views: 1006
4:32
Acute promyelocytic leukemia (APL) illness script video
- Order: Reorder
- Duration: 4:32
- Uploaded Date: 26 Jan 2024
- views: 251
More content on RLRCPSolvers.com
Myeloblast w/ Auer rod
https://imagebank.hematology.org/atlas/60924
Microgranular variant (no Auer rods or granules but the ...
More content on RLRCPSolvers.com
Myeloblast w/ Auer rod
https://imagebank.hematology.org/atlas/60924
Microgranular variant (no Auer rods or granules but the bi-lobed nuclei are the tip-off) https://imagebank.hematology.org/collection/111
https://wn.com/Acute_Promyelocytic_Leukemia_(Apl)_Illness_Script_Video
More content on RLRCPSolvers.com
Myeloblast w/ Auer rod
https://imagebank.hematology.org/atlas/60924
Microgranular variant (no Auer rods or granules but the bi-lobed nuclei are the tip-off) https://imagebank.hematology.org/collection/111
- published: 26 Jan 2024
- views: 251
1:03
ACUTE PROMYELOCYTIC LEUKEMIA – SYMPTOMS, TREATMENT & SUPPORT
- Order: Reorder
- Duration: 1:03
- Uploaded Date: 07 Feb 2023
- views: 715
What Is Acute Promyelocytic Leukemia?
https://withoutaribbon.org/acute-promyelocytic-leukemia-symptoms-treatment-support/
Acute Promyelocytic #Leukemia is a bon...
What Is Acute Promyelocytic Leukemia?
https://withoutaribbon.org/acute-promyelocytic-leukemia-symptoms-treatment-support/
Acute Promyelocytic #Leukemia is a bone marrow malignancy in which the myeloid line of cells( red blood cells, white blood cells and platelets forming cells) has a shortage of mature white blood cells and an excess of immature progenitor (ancestor) white blood cells, called promyelocytes.
Disease Epidemiology
Acute Promyelocytic Leukemia (APL) constitutes 5-15 per cent of all adult leukemia in the United States. #APL in Italy has an annual incidence rate (frequency of occurrence of disease) of around 0.6 per 1 million populations. Both males and females are equally affected. The age of onset of the disease is about 40 years.
Disease Prognosis
Unlike other leukemias, acute #promyelocytic leukemia shows a good prognosis. Following treatment, the long term survival rate is up to 90%. Besides, the rate of premature death remains high, with 29 per cent of APL patients dying within about 30 days of their diagnosis, among these cases of early deaths 35% of patients never received specific therapy for acute promyelocytic Leukemia. Hemorrhage (bleeding), differentiation syndrome (DS), and infection are the main causes of premature death with APL.
#leukemiaawareness
https://wn.com/Acute_Promyelocytic_Leukemia_–_Symptoms,_Treatment_Support
What Is Acute Promyelocytic Leukemia?
https://withoutaribbon.org/acute-promyelocytic-leukemia-symptoms-treatment-support/
Acute Promyelocytic #Leukemia is a bone marrow malignancy in which the myeloid line of cells( red blood cells, white blood cells and platelets forming cells) has a shortage of mature white blood cells and an excess of immature progenitor (ancestor) white blood cells, called promyelocytes.
Disease Epidemiology
Acute Promyelocytic Leukemia (APL) constitutes 5-15 per cent of all adult leukemia in the United States. #APL in Italy has an annual incidence rate (frequency of occurrence of disease) of around 0.6 per 1 million populations. Both males and females are equally affected. The age of onset of the disease is about 40 years.
Disease Prognosis
Unlike other leukemias, acute #promyelocytic leukemia shows a good prognosis. Following treatment, the long term survival rate is up to 90%. Besides, the rate of premature death remains high, with 29 per cent of APL patients dying within about 30 days of their diagnosis, among these cases of early deaths 35% of patients never received specific therapy for acute promyelocytic Leukemia. Hemorrhage (bleeding), differentiation syndrome (DS), and infection are the main causes of premature death with APL.
#leukemiaawareness
- published: 07 Feb 2023
- views: 715
PLAYLIST TIME:
PLAYLIST TIME:
3:52
Timely Diagnosis of Acute Promyelocytic Leukemia
Ehab Atallah, MD, and Elihu Estey, MD, discuss differential diagnosis, testing, and initia...
published: 17 Jan 2017
Timely Diagnosis of Acute Promyelocytic Leukemia
Timely Diagnosis of Acute Promyelocytic Leukemia
- Report rights infringement
- published: 17 Jan 2017
- views: 3849
Ehab Atallah, MD, and Elihu Estey, MD, discuss differential diagnosis, testing, and initiation of treatment in acute promyelocytic leukemia (APL).
5:05
Acute Promyelocytic Leukemia | Jaclyn's Story
Jaclyn was diagnosed with a rare subtype of acute myeloid leukemia (AML) -- acute promyelo...
published: 18 Dec 2019
Acute Promyelocytic Leukemia | Jaclyn's Story
Acute Promyelocytic Leukemia | Jaclyn's Story
- Report rights infringement
- published: 18 Dec 2019
- views: 7982
Jaclyn was diagnosed with a rare subtype of acute myeloid leukemia (AML) -- acute promyelocytic leukemia -- requiring immediate treatment. See how Dr. Gail Roboz and the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian went above and beyond to help Jaclyn achieve remission and kickstart a healthy lifestyle.
Learn more about our Leukemia Program:
https://weillcornell.org/leukemia
17:42
Treating Acute Promyelocytic Leukemia (APL)
Anand P. Jillella, MD of the Winship Cancer Institute of Atlanta, GA, discusses best pract...
published: 30 Dec 2015
Treating Acute Promyelocytic Leukemia (APL)
Treating Acute Promyelocytic Leukemia (APL)
- Report rights infringement
- published: 30 Dec 2015
- views: 21205
Anand P. Jillella, MD of the Winship Cancer Institute of Atlanta, GA, discusses best practices, treatment, standard of care for APL, role of clinical trials, complications that may arise during treatment, treating a relapsed patient, and the importance of a good relationship with your patients. Kaitlin L. Sitchenko, CCRC discusses the role of clinical trials in treatment. APL survivors, Julie and June each share their story about their APL diagnosis and treatment.
To view additional videos, visit http://www.LLS.org/educationvideos.
or your feedback at http://www.cancereducation.com/cancer....
Support for this video provided by Teva Oncology.
5:10
Acute Promyelocytic Leukemia (APL): microgranular vs classic (cottage loaf cells). Hematology
This clip is an excerpt from a Hemepath Board Review video by special guest, Dr. Jeanette ...
published: 29 Mar 2021
Acute Promyelocytic Leukemia (APL): microgranular vs classic (cottage loaf cells). Hematology
Acute Promyelocytic Leukemia (APL): microgranular vs classic (cottage loaf cells). Hematology
- Report rights infringement
- published: 29 Mar 2021
- views: 6524
This clip is an excerpt from a Hemepath Board Review video by special guest, Dr. Jeanette Ramos (full video here: https://kikoxp.com/posts/3726). If you missed Dr. Ramos's first guest lecture discussing the histology and immunostaining patterns of non-neoplastic lymph nodes, check it out here: https://kikoxp.com/posts/4068.
If you like Dr. Ramos's cases and teaching style, be sure to follow UAMS Hematopathology on social media, as she often contributes to their accounts:
- https://twitter.com/hemepathuams
- https://www.facebook.com/hemepathUAMS/
This video is geared towards medical students, pathology/internal medicine/family practice residents, hematology or hematopathology fellows, or practicing pathologists or hematologists. Of course, this video is for educational purposes only and is not formal medical advice or consultation. Neither Dr. Ramos nor Dr. Gardner have any special inside knowledge of the content of the path/heme/hemepath/USMLE board examinations. This video is subjectively labeled as a "board review" purely because we believe these topics are potentially testable entities, not because we have any knowledge about the frequency that they will show up on actual board exams.
Please subscribe to my channel to be notified of new pathology teaching videos.
Follow me on:
Snapchat: JMGardnerMD
Twitter: @JMGardnerMD
Instagram: @JMGardnerMD
Kiko: https://kikoxp.com/profile/jerad_gardner1/content?filter=popular
Facebook: https://www.facebook.com/JMGardnerMD/
7:29
Acute Promyelocytic Leukema (aPML) - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology
Acute Promyelocytic Leukema (aPML) - Acute Myeloid Leukemia (AML) Subtype: M3 - AML/ M3 Su...
published: 24 Jul 2018
Acute Promyelocytic Leukema (aPML) - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology
Acute Promyelocytic Leukema (aPML) - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology
- Report rights infringement
- published: 24 Jul 2018
- views: 87880
Acute Promyelocytic Leukema (aPML) - Acute Myeloid Leukemia (AML) Subtype: M3 - AML/ M3 Subtype - t(15;17) - Vitamin A (ATRA) - Hematology.
Acute Promyelocytic Leukema (aPML) is a chromosomal translocation: t(15;17) translocation...AML-M3 is associated with disseminated intravascular coagulation (DIC)...Treated with ATRA (tretinoin) which is vitamin A (can cause differentiation syndrome). aPML can also be treated with Arsenic trioxide.
😍🖼Animated Mnemonics (Picmonic): https://www.picmonic.com/viphookup/medicosis/
Disclaimer: I use affiliate links....
►👨🏫💊Antibiotics Lectures: https://www.medicosisperfectionalis.com/products/courses/antibiotics/ ... Course
If you like my videos, please consider leaving a tip at https://www.paypal.me/perfectionalis/
► Visit my website: https://www.medicosisperfectionalis.com/
My Favorite Productivity App: https://airtable.com/invite/r/2zH40fus/
📱Save on your mobile phone bill: http://fbuy.me/q6bMj
🏦 Qbank (TrueLearn): https://truelearn.referralrock.com/l/MEDICOSIS/
2:50
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy, discusses the use of ...
published: 07 Mar 2017
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
- Report rights infringement
- published: 07 Mar 2017
- views: 2333
Francesco Lo-Coco, MD, from the University Tor Vergata, Rome, Italy, discusses the use of a chemo-free approach combining arsenic trioxide (ATO) with all-trans retinoic acid (ATRA), which is superior to a conventional approach in the treatment of acute promyelocytic leukemia (APL, APML). He describes how this will now be examined in a randomized study in high-risk APML patients comparing arsenic in combination with all-trans-retinoic acid to chemotherapy. Prof. Lo-Coco explains that high-risk APML patients are defined as those with an initial white blood cell count greater than 10 000. The trial aims to demonstrate a benefit in event-free survival (EFS) using the new compound. Prof. Lo Coco points out that APML is now a highly curable disease, and explains that the hope is to come to a new standard particularly avoiding toxicity. He is hopeful that the chemo-free approach can be expanded to high-risk patients, but highlights the challenges of this trial due to the fact that high-risk APML is a rare disease, exhibited by only a quarter of APML patients. Prof. Lo-Coco emphasizes the value of collaboration with other European partners in this trial.
4:06
Kate Stallard - Acute Promyelocytic Leukaemia patient story
published: 01 Oct 2018
Kate Stallard - Acute Promyelocytic Leukaemia patient story
Kate Stallard - Acute Promyelocytic Leukaemia patient story
- Report rights infringement
- published: 01 Oct 2018
- views: 11838
27:39
Acute Promyelocytic Leukemia(AML M3) | Dr. G Krishna Reddy| Oncologists| Manipal Hospital Vijayawada
Acute Promyelocytic Leukaemia (AML M3) is a type of blood cancer that causes immature and ...
published: 11 Jan 2023
Acute Promyelocytic Leukemia(AML M3) | Dr. G Krishna Reddy| Oncologists| Manipal Hospital Vijayawada
Acute Promyelocytic Leukemia(AML M3) | Dr. G Krishna Reddy| Oncologists| Manipal Hospital Vijayawada
- Report rights infringement
- published: 11 Jan 2023
- views: 1006
Acute Promyelocytic Leukaemia (AML M3) is a type of blood cancer that causes immature and abnormal neutrophils, a type of white blood cell, to accumulate in a patient’s bone marrow. In this video, Dr. G Krishna Reddy, Consultant – Medical Oncologist and Bone Marrow Transplant Physician, Manipal Hospital Vijayawada, shares details about this condition and discusses treatment options.
At Manipal Hospital Vijayawada, our Centre of Excellence in Oncology (Cancer Care) adopts a holistic approach to provide the complete treatment of an entire spectrum of cancers at all stages. With expertise in all clinical specialties in oncology, such as medical (immunotherapy, targeted therapy, hormone therapy and chemotherapy), surgical, haematology, bone marrow transplant and radiation therapy, our proficient team of cancer specialists promises quality treatment and care.
They have years of experience in diagnosing some of the most challenging cases, staging the illness, treating with radiotherapy or medications and operating with state-of-the-art equipment and technology. To stay true to our ethos of patient centricity and clinical excellence, we prioritize quaternary care to ensure timely diagnosis and treatment of all cancers.
At Manipal Hospital Vijayawada, we have a dedicated tumour board for cancer patients. We believe that each patient is unique and thus, helps us learn about the various aspects of cancer care and treatment. With this dedicated tumour board, we encourage exhaustive discussions and studies on each case to come up with the best possible treatment. Moreover, we follow internationally approved and evidence-based chemotherapy guidelines for the treatment of haematological and solid cancers.
Know More
View Full Doctor Profile: https://www.manipalhospitals.com/vijayawada/doctors/dr-g-krishna-reddy-consultant-medical-oncologist-bone-marrow-transplant-physician/
Visit Our Hospital Website: https://www.manipalhospitals.com/
Visit Our Cancer Care Doctors: https://www.manipalhospitals.com/vijayawada/doctors-list/cancer-care/
Visit for Cancer Care Department: https://www.manipalhospitals.com/vijayawada/specialities/cancer-care/
Contact us @ https://www.manipalhospitals.com/contact-us/
Get Connected Here:
==================
Facebook: https://www.facebook.com/ManipalHospitalsIndia
Twitter: https://twitter.com/ManipalHealth
Pinterest: https://in.pinterest.com/manipalhospital
LinkedIn: https://www.linkedin.com/company/manipal-hospital
Instagram: https://www.instagram.com/manipalhospitals/
Foursquare: https://foursquare.com/manipalhealth
Alexa: https://www.alexa.com/siteinfo/manipalhospitals.com
Blog: https://www.manipalhospitals.com/vijayawada/blog/
#ManipalHospitalVijayawada #YourManipal #LifesOn #Healthcare #APML #Oncology #Leukaemia #Bonemarrowtransplant #Bloodcancer
For appointments call:-1800 102 5555
Visit:https://www.manipalhospitals.com/vijayawada/doctors/dr-g-krishna-reddy-consultant-medical-oncologist-bone-marrow-transplant-physician/
4:32
Acute promyelocytic leukemia (APL) illness script video
More content on RLRCPSolvers.com
Myeloblast w/ Auer rod
https://imagebank.hematology.org...
published: 26 Jan 2024
Acute promyelocytic leukemia (APL) illness script video
Acute promyelocytic leukemia (APL) illness script video
- Report rights infringement
- published: 26 Jan 2024
- views: 251
More content on RLRCPSolvers.com
Myeloblast w/ Auer rod
https://imagebank.hematology.org/atlas/60924
Microgranular variant (no Auer rods or granules but the bi-lobed nuclei are the tip-off) https://imagebank.hematology.org/collection/111
1:03
ACUTE PROMYELOCYTIC LEUKEMIA – SYMPTOMS, TREATMENT & SUPPORT
What Is Acute Promyelocytic Leukemia?
https://withoutaribbon.org/acute-promyelocytic-leuke...
published: 07 Feb 2023
ACUTE PROMYELOCYTIC LEUKEMIA – SYMPTOMS, TREATMENT & SUPPORT
ACUTE PROMYELOCYTIC LEUKEMIA – SYMPTOMS, TREATMENT & SUPPORT
- Report rights infringement
- published: 07 Feb 2023
- views: 715
What Is Acute Promyelocytic Leukemia?
https://withoutaribbon.org/acute-promyelocytic-leukemia-symptoms-treatment-support/
Acute Promyelocytic #Leukemia is a bone marrow malignancy in which the myeloid line of cells( red blood cells, white blood cells and platelets forming cells) has a shortage of mature white blood cells and an excess of immature progenitor (ancestor) white blood cells, called promyelocytes.
Disease Epidemiology
Acute Promyelocytic Leukemia (APL) constitutes 5-15 per cent of all adult leukemia in the United States. #APL in Italy has an annual incidence rate (frequency of occurrence of disease) of around 0.6 per 1 million populations. Both males and females are equally affected. The age of onset of the disease is about 40 years.
Disease Prognosis
Unlike other leukemias, acute #promyelocytic leukemia shows a good prognosis. Following treatment, the long term survival rate is up to 90%. Besides, the rate of premature death remains high, with 29 per cent of APL patients dying within about 30 days of their diagnosis, among these cases of early deaths 35% of patients never received specific therapy for acute promyelocytic Leukemia. Hemorrhage (bleeding), differentiation syndrome (DS), and infection are the main causes of premature death with APL.
#leukemiaawareness
Acute promyelocytic leukemia
Acute promyelocytic leukemia (APML, APL) is the M3 subtype of acute myelogenous leukemia (AML), a cancer of the white blood cells. In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy. Acute promyelocytic leukemia was first characterized in 1957 by French and Norwegian physicians as a hyperacute fatal illness. Currently it is one of the most treatable forms of leukemia with a 12-year progression-free survival rate that is estimated to be approximately 70%.
Signs and symptoms
The symptoms tend to be similar to AML in general with the following being possible symptoms:
This page contains text from Wikipedia, the Free Encyclopedia - https://wn.com/Acute_promyelocytic_leukemia
Timely Diagnosis of Acute Promyelocytic Leukemia...
Acute Promyelocytic Leukemia | Jaclyn's Story...
Treating Acute Promyelocytic Leukemia (APL)...
Acute Promyelocytic Leukemia (APL): microgranular ...
Acute Promyelocytic Leukema (aPML) - AML/ M3 Subty...
Chemo-free approach in acute promyelocytic leukemi...
Kate Stallard - Acute Promyelocytic Leukaemia pati...
Acute Promyelocytic Leukemia(AML M3) | Dr. G Krish...
Acute promyelocytic leukemia (APL) illness script ...
